techcrunch
PublishedJuly 15, 2026 at 12:27 AM
—neutral
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Publisher summary· verbatim
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
Stay posted· Newsletter
A 5-min weekly brief — top movers, price watch, story of the week.
Discussion
No replies yet. Be first.
Related coverage
More from TECHCRUNCH
techcrunchHow Apple’s big lawsuit could disrupt OpenAI’s IPO plans1htechcrunchPatreon stops asking AI bots not to scrape — and starts blocking them4htechcrunchApple’s lawsuit couldn’t come at a worse time for OpenAI5htechcrunchWhy the first GPU financiers are turning to inference chips in a $400 million deal7hThe Bubble Brief
WEEKLYRead AI insights every Tuesday — top movers, new releases, story of the week.
Originally published on techcrunch ↗